© 1991 by Oxford University Press
Journal of the National Cancer Institute, Vol. 83, No. 11, 775-779,
June 5, 1991
© 1991 Oxford University Press
Tumor Cell Invasion Inhibited by TIMP-2
CNR Biotecnologie e Biosvurnentazione grant 90.00140.PF70
Instituto Nazionale per la Ricerca sul Cancro Genoa, Italy
Laboratory of Pathology, National Cancer Institute Betheda, Md
*Correspondence to: William G. Stetler-Stevenson, MD, PhD, Bldg 10, Rm 2,433, National Institutes of Health, Rethesda MD 20892
The 72-kd type IV collagenase is a member of the collagenase enzyme family that has been closely linked with the invasive phenotype of cancer cells. Previous studies have shown that both normal cells and highly invasive tumor cells produce the 72-kd type IV procollagenase enzyme in a complexed form consisting of the proenzyme and a novel tissue inhibitor of metalloproteinases, TIMP-2. The balance between activated enzyme and available inhibitor is thought to be a critical determinant of the matrix proteolysis associated with a variety of pathologic processes, including tumor cell invasion. In the present study, we demonstrate that alteration of the metalloproteinase-metalloproteinase-inhibitor balance in favor of excess inhibitor blocks human fibrosarcoma HT-1080 tumor cell invasion of a reconstituted basement membrane. The HT-1080 cell line prduces both the 72-kd and the 92-kd type IV collagenases. Alteration of the type IV collagenase-inhibitor balance was achieved by addition of free TIMP-2 or antibodies to 72-kd type IV collagenase. Native, purified TIMP-2 was inhibitory in the range of 1·25 µg/mL. Addition of specific antiserum against the 72-kd type IV collagenase, which did not cross-react with the 92-kd type IV collagenase, inhibited HT-1080 cell invasion to the same extent. These results suggest that metalloproteinases, in particular the 72-kd type IV collagenase, are critical for tumor cell invasion of the reconstituted basement membrane. Our findings demonstrate that addition of the endogenous inhibitor TIMP-2 is able to block invasion. Thus, we recommend initiation of in vivo studies of the therapeutic potential of TIMP-2 to block tumor cell invasion and intravasation into the circulation.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Yan, C. Zhou, X. Lou, Z. Xiao, H. Zhu, Q. Wang, Y. Wang, N. Lu, S. He, Q. Zhan, et al. PTTG Overexpression Promotes Lymph Node Metastasis in Human Esophageal Squamous Cell Carcinoma Cancer Res., April 15, 2009; 69(8): 3283 - 3290. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. G. Stetler-Stevenson Tissue Inhibitors of Metalloproteinases in Cell Signaling: Metalloproteinase-Independent Biological Activities Sci. Signal., July 8, 2008; 1(27): re6 - re6. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. D'Alessio, G. Ferrari, K. Cinnante, W. Scheerer, A. C. Galloway, D. F. Roses, D. V. Rozanov, A. G. Remacle, E.-S. Oh, S. A. Shiryaev, et al. Tissue Inhibitor of Metalloproteinases-2 Binding to Membrane-type 1 Matrix Metalloproteinase Induces MAPK Activation and Cell Growth by a Non-proteolytic Mechanism J. Biol. Chem., January 4, 2008; 283(1): 87 - 99. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. W.T. Cheung, P. C.K. Leung, and A. S.T. Wong Gonadotropin-Releasing Hormone Promotes Ovarian Cancer Cell Invasiveness through c-Jun NH2-Terminal Kinase-Mediated Activation of Matrix Metalloproteinase (MMP)-2 and MMP-9. Cancer Res., November 15, 2006; 66(22): 10902 - 10910. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Yamazaki, T. Akahane, T. Buck, H. Yoshiji, D. E. Gomez, D. J. Schoeffner, E. Okajima, S. R. Harris, O. R. Bunce, S. S. Thorgeirsson, et al. Long-term exposure to elevated levels of circulating TIMP-1 but not mammary TIMP-1 suppresses growth of mammary carcinomas in transgenic mice Carcinogenesis, September 1, 2004; 25(9): 1735 - 1746. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W.-H. Yoon, Y.-J. Jung, T.-D. Kim, G. Li, B.-J. Park, J.-Y. Kim, Y.-C. Lee, J.-M. Kim, J.-I. Park, H.-D. Park, et al. Gabexate Mesilate Inhibits Colon Cancer Growth, Invasion, and Metastasis by Reducing Matrix Metalloproteinases and Angiogenesis Clin. Cancer Res., July 1, 2004; 10(13): 4517 - 4526. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-G. Zhao, A.-Z. Xiao, H. I. Park, R. G. Newcomer, M. Yan, Y.-G. Man, S. C. Heffelfinger, and Q.-X. A. Sang Endometase/Matrilysin-2 in Human Breast Ductal Carcinoma in Situ and Its Inhibition by Tissue Inhibitors of Metalloproteinases-2 and -4: A Putative Role in the Initiation of Breast Cancer Invasion Cancer Res., January 15, 2004; 64(2): 590 - 598. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Owen, V. Iragavarapu-Charyulu, Z. Gunja-Smith, L. M. Herbert, J. F. Grosso, and D. M. Lopez Up-Regulation of Matrix Metalloproteinase-9 in T Lymphocytes of Mammary Tumor Bearers: Role of Vascular Endothelial Growth Factor J. Immunol., October 15, 2003; 171(8): 4340 - 4351. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-M. Su, Y.-Q. Wei, L. Tian, X. Zhao, L. Yang, Q.-M. He, Y. Wang, Y. Lu, Y. Wu, F. Liu, et al. Active Immunogene Therapy of Cancer with Vaccine On the Basis of Chicken Homologous Matrix Metalloproteinase-2 Cancer Res., February 1, 2003; 63(3): 600 - 607. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. Tam, Y. I. Wu, G. S. Butler, M. S. Stack, and C. M. Overall Collagen Binding Properties of the Membrane Type-1 Matrix Metalloproteinase (MT1-MMP) Hemopexin C Domain. THE ECTODOMAIN OF THE 44-kDa AUTOCATALYTIC PRODUCT OF MT1-MMP INHIBITS CELL INVASION BY DISRUPTING NATIVE TYPE I COLLAGEN CLEAVAGE J. Biol. Chem., October 4, 2002; 277(41): 39005 - 39014. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. A. Bannikov, T. V. Karelina, I. E. Collier, B. L. Marmer, and G. I. Goldberg Substrate Binding of Gelatinase B Induces Its Enzymatic Activity in the Presence of Intact Propeptide J. Biol. Chem., May 3, 2002; 277(18): 16022 - 16027. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. T. Ho, E. B. Voura, P. D. Soloway, K. L. M. Watson, and R. Khokha MMP Inhibitors Augment Fibroblast Adhesion through Stabilization of Focal Adhesion Contacts and Up-regulation of Cadherin Function J. Biol. Chem., October 19, 2001; 276(43): 40215 - 40224. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. V. S. Kallakury, S. Karikehalli, A. Haholu, C. E. Sheehan, N. Azumi, and J. S. Ross Increased Expression of Matrix Metalloproteinases 2 and 9 and Tissue Inhibitors of Metalloproteinases 1 and 2 Correlate with Poor Prognostic Variables in Renal Cell Carcinoma Clin. Cancer Res., October 1, 2001; 7(10): 3113 - 3119. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Guedez, A. J. McMarlin, D. W. Kingma, T. A. Bennett, M. Stetler-Stevenson, and W. G. Stetler-Stevenson Tissue Inhibitor of Metalloproteinase-1 Alters the Tumorigenicity of Burkitt's Lymphoma via Divergent Effects on Tumor Growth and Angiogenesis Am. J. Pathol., April 1, 2001; 158(4): 1207 - 1215. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. W. Slaton, K. Inoue, P. Perrotte, A. K. El-Naggar, D. A. Swanson, I. J. Fidler, and C. P. N. Dinney Expression Levels of Genes that Regulate Metastasis and Angiogenesis Correlate with Advanced Pathological Stage of Renal Cell Carcinoma Am. J. Pathol., February 1, 2001; 158(2): 735 - 743. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Bjornland, J. O. Winberg, O. T. Odegaard, E. Hovig, T. Loennechen, A. O. Aasen, O. Fodstad, and G. M. Malandsmo S100A4 Involvement in Metastasis: Deregulation of Matrix Metalloproteinases and Tissue Inhibitors of Matrix Metalloproteinases in Osteosarcoma Cells Transfected with an Anti-S100A4 Ribozyme Cancer Res., September 1, 1999; 59(18): 4702 - 4708. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Sehgal and T. C. Thompson Novel Regulation of Type IV Collagenase (Matrix Metalloproteinase-9 and -2) Activities by Transforming Growth Factor-beta 1 in Human Prostate Cancer Cell Lines Mol. Biol. Cell, February 1, 1999; 10(2): 407 - 416. [Abstract] [Full Text]
|
|
|
|
|
|
H. Kuniyasu, L. M. Ellis, D. B. Evans, J. L. Abbruzzese, C. J. Fenoglio, C. D. Bucana, K. R. Cleary, E. Tahara, and I. J. Fidler Relative Expression of E-Cadherin and Type IV Collagenase Genes Predicts Disease Outcome in Patients with Resectable Pancreatic Carcinoma Clin. Cancer Res., January 1, 1999; 5(1): 25 - 33. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G I Murray, M E Duncan, E Arbuckle, W T Melvin, and J E Fothergill Matrix metalloproteinases and their inhibitors in gastric cancer Gut, December 1, 1998; 43(6): 791 - 797. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Bellosta, D. Via, M. Canavesi, P. Pfister, R. Fumagalli, R. Paoletti, and F. Bernini HMG-CoA Reductase Inhibitors Reduce MMP-9 Secretion by Macrophages Arterioscler Thromb Vasc Biol, November 1, 1998; 18(11): 1671 - 1678. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. D. Kenagy, C. E. Hart, W. G. Stetler-Stevenson, and A. W. Clowes Primate Smooth Muscle Cell Migration From Aortic Explants Is Mediated by Endogenous Platelet-Derived Growth Factor and Basic Fibroblast Growth Factor Acting Through Matrix Metalloproteinases 2 and 9 Circulation, November 18, 1997; 96(10): 3555 - 3560. [Abstract] [Full Text]
|
|
|
|
|
|
Y. E. Liu, M. Wang, J. Greene, J. Su, S. Ullrich, H. Li, S. Sheng, P. Alexander, Q. A. Sang, and Y. E. Shi Preparation and Characterization of Recombinant Tissue Inhibitor of Metalloproteinase 4 (TIMP-4) J. Biol. Chem., August 15, 1997; 272(33): 20479 - 20483. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. F. Singer, A. Rasmussen, M. E. Lippman, and K. J. Cullen Coexpression of Stromelysin-3 and Insulin-Like Growth Factor II in Tumors of Ectodermal, Mesodermal, and Endodermal Origin: Indicator of a Fetal Cell Phenotype J. Clin. Endocrinol. Metab., June 1, 1997; 82(6): 1917 - 1922. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. H. Bu and T. Pourmotabbed Mechanism of Ca2+-dependent Activity of Human Neutrophil Gelatinase B J. Biol. Chem., June 14, 1996; 271(24): 14308 - 14315. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Kylmaniemi, A. Oikarinen, K. Oikarinen, and T. Salo Effects of Dexamethasone and Cell Proliferation on the Expression of Matrix Metalloproteinases in Human Mucosal Normal and Malignant Cells Journal of Dental Research, March 1, 1996; 75(3): 919 - 926. [Abstract] [PDF]
|
|
|
|
|
|
C. H. Bu and T. Pourmotabbed Mechanism of Activation of Human Neutrophil Gelatinase B J. Biol. Chem., August 4, 1995; 270(31): 18563 - 18569. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. Corcoran and W. G. Stetler-Stevenson Tissue Inhibitor of Metalloproteinase-2 Stimulates Fibroblast Proliferation via a cAMP-dependent Mechanism J. Biol. Chem., June 2, 1995; 270(22): 13453 - 13459. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Birkedal-Hansen, W.G.I. Moore, M.K. Bodden, L.J. Windsor, B. Birkedal-Hansen, A. DeCarlo, and J.A. Engler Matrix Metalloproteinases: A Review Critical Reviews in Oral Biology & Medicine, January 1, 1993; 4(2): 197 - 250. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. E. Hoegy, H.-R. Oh, M. L. Corcoran, and W. G. Stetler-Stevenson Tissue Inhibitor of Metalloproteinases-2 (TIMP-2) Suppresses TKR-Growth Factor Signaling Independent of Metalloproteinase Inhibition J. Biol. Chem., January 26, 2001; 276(5): 3203 - 3214. [Abstract] [Full Text] [PDF]
|
|